Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verastem (VSTM) Shares Outstanding (Diluted Average) (2018 - 2025)

Verastem (VSTM) has 8 years of Shares Outstanding (Diluted Average) data on record, last reported at $69.3 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 94.07% year-over-year to $69.3 million; the TTM value through Dec 2025 reached $69.3 million, up 94.07%, while the annual FY2025 figure was $69.3 million, 94.07% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $69.3 million in Q4 2025 per VSTM's latest filing, up from $64.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $200.7 million in Q1 2023 and bottomed at $14.5 million in Q4 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $97.4 million, with a median of $64.6 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): soared 9379.55% in 2021, then plummeted 86.63% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $14.5 million in 2021, then increased by 11.03% to $16.1 million in 2022, then surged by 36.66% to $22.1 million in 2023, then surged by 61.93% to $35.7 million in 2024, then soared by 94.07% to $69.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $69.3 million in Q4 2025, $64.6 million in Q3 2025, and $54.2 million in Q1 2025.